Inactivated influenza vaccines prepared in cell culture: proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | German |
Veröffentlicht: |
Basel [u.a.]
Karger
1999
|
Schriftenreihe: | Developments in biological standardization
98 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Literaturangaben |
Beschreibung: | IX, 209 S. graph. Darst. |
ISBN: | 3805568967 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV012807913 | ||
003 | DE-604 | ||
005 | 20210702 | ||
007 | t | ||
008 | 991012s1999 gw d||| |||| 10||| ger d | ||
020 | |a 3805568967 |c kart. : DM 240.00 |9 3-8055-6896-7 | ||
035 | |a (OCoLC)313614372 | ||
035 | |a (DE-599)BVBBV012807913 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a ger | |
044 | |a gw |c DE | ||
049 | |a DE-355 |a DE-12 |a DE-11 | ||
084 | |a XD 7255 |0 (DE-625)152592:13134 |2 rvk | ||
084 | |a XD 7950 |0 (DE-625)152605:13129 |2 rvk | ||
245 | 1 | 0 | |a Inactivated influenza vaccines prepared in cell culture |b proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables |c Organized and sponsored by the National Institute for Biological Standards and Control (NIBSC) ... Vol. ed. Fred Brown ... |
264 | 1 | |a Basel [u.a.] |b Karger |c 1999 | |
300 | |a IX, 209 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Developments in biological standardization |v 98 | |
500 | |a Literaturangaben | ||
650 | 0 | 7 | |a Virusimpfstoff |0 (DE-588)4257636-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Biologische Standardisierung |0 (DE-588)4336303-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Zellkultur |0 (DE-588)4067547-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Influenzaviren |0 (DE-588)4254831-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Grippe |0 (DE-588)4022090-4 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1997 |z Potters Bar |2 gnd-content | |
689 | 0 | 0 | |a Influenzaviren |0 (DE-588)4254831-7 |D s |
689 | 0 | 1 | |a Virusimpfstoff |0 (DE-588)4257636-2 |D s |
689 | 0 | 2 | |a Zellkultur |0 (DE-588)4067547-6 |D s |
689 | 0 | 3 | |a Biologische Standardisierung |0 (DE-588)4336303-9 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Grippe |0 (DE-588)4022090-4 |D s |
689 | 1 | 1 | |a Virusimpfstoff |0 (DE-588)4257636-2 |D s |
689 | 1 | 2 | |a Zellkultur |0 (DE-588)4067547-6 |D s |
689 | 1 | 3 | |a Biologische Standardisierung |0 (DE-588)4336303-9 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Brown, Fred |d 1925-2004 |e Sonstige |0 (DE-588)171991923 |4 oth | |
710 | 2 | |a National Institute for Biological Standards and Control (Großbritannien) |e Sonstige |0 (DE-588)5123324-1 |4 oth | |
830 | 0 | |a Developments in biological standardization |v 98 |w (DE-604)BV000000884 |9 98 | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008711074&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-008711074 |
Datensatz im Suchindex
_version_ | 1804127480285495296 |
---|---|
adam_text | Contents
Introduction 1
Introduction 3
J.M. Wood
Session I
Isolation and Cultivation of Influenza Virus on Mammalian Cells S
Chairperson: G.C. Schild
An Overview of Host Cell Selection 7
J.S. Robertson
Suitability of MDCK Cells Grown in a Serum Free Medium for Influenza Virus Production 13
N. Kessler, G. Thomas Roche, L. Gerentes, M. Aymard
Production of Influenza Virus in Serum Free Mammalian Cell Cultures 23
O WMerten, J.C. Manuguerra, C. Hannoun, S. van der Werf
Growth and Immunogenicity of Influenza Viruses Cultivated in Vero or MDCK Cells and
in Embryonated Chicken Eggs 39
E.A. Govorkova, S. Kodihalli, IV. Alymova, B. Fanget, R.G. Webster
Evaluation of Immune Responses to Inactivated Influenza Vaccines Prepared in Embryo¬
nated Chicken Eggs and MDCK Cells in a Mouse Model 53
K. Nerome, H. Kumihashi, R. Nerome, Y Hiromoto, Y. Yokota, R. Veda, K. Omoe,
M. Chiba
Cell Culture for Surveillance of Influenza 65
M. Zambon
Discussion 73
Session II
Selection of Vaccine Strains 75
Chairperson: P.D. Minor
Generation and Characterisation of Reassortant Influenza A Viruses Propagated in Serum
Free Cultured MDCK SF1 Cells 77
J.T.M. Voeten, E.C.J. Claas, R. Brands, A.M. Palache, G.J.M. van Scharrenburg,
G.F. Rimmelzwaan, A.D.M.E. Osterhaus
Discussion 89
VII
Session 111
Scale up for Vaccine Production 91
Chairperson: /. Furminger
Influvac TC: A Safe Madin Darby Canine Kidney (MDCK) Cell Culture Based Influenza Vaccine 93
R. Brands, J. Visser, J. Medema, A.M. Palache, G.J.M. van Scharrenburg
Development of a Vero Cell Derived Influenza Whole Virus Vaccine 101
O. Kistner, P.N. Barrett, W. Mundt, M. Reiter, S. Schober Bendixen, G. Eder, F. Dorner
Discussion Ill
Session IV
Clinical Trials 113
Chairperson: K. Nicholson
Safety, Reactogenicity and Immunogenicity of Madin Darby Canine Kidney Cell Derived
Inactivated Influenza Subunit Vaccine. A Meta Analysis of Clinical Studies 115
A.M. Palache, H.S.J. Scheepers, V. de Regt, P. van Ewijk, M.Baljet, R. Brands,
G.J.M. van Scharrenburg
A Phase I, Randomised Controlled Clinical Trial to Study the Reactogenicity and Immuno¬
genicity of a New Split Influenza Vaccine Derived from a Non Tumorigenic Cell Line 127
P.B. Percheson, P. Tripanier, R. Dugre, T. Mabrouk
Discussion 133
Session V
General Regulatory Issues (1): Cell Substrates 13S
Chairperson: E. Griffiths
Experience with Vero Cell at Pasteur Merieux Connaught 137
B.J. Montagnon, J.C. Vincent Falquet, J.F. Saluzzo
Quality Assurance for Cell Substrates 141
G.N. Stacey, P. Phillips
WHO Requirements for the Use of Animal Cells as In Vitro Substrates for the Production
of Biologicals: Application to Influenza Vaccine Production 153
E. Griffiths
ICH Guidelines and PhEur Monographs on Derivation and Characterisation of Cell Sub¬
strates Used for Production of Biotechnological/Biological Products 159
R. Dobbelaer
Discussion 167
Session VI
General Regulatory Issues (2): Cell Culture Influenza Vaccines 169
Chairperson: R.A. Levandowski
Regulatory Perspective in the United States on Cell Cultures for Production of Inactivated
Influenza Virus Vaccines 171
R.A. Levandowski
V 11 Contents
Cell Culture Influenza Vaccine: An Australian Perspective 177
L. Chang, R. Crichton, P. Nandapalan
The Influence of the Host Cell on Standardisation of Influenza Vaccine Potency 183
J.M. Wood, U. Dunleavy, R.W. Newman, A.M. Riley, J.S. Robertson, P.D. Minor
Difficulties in Standardizing the Neuraminidase Content of Influenza Vaccines 189
L. Gerentes, N. Kessler, M. Aymard
Discussion 197
Session VII
Summary and Recommendations 199
Summary and Recommendations 201
P.D. Minor
Contents IX
|
any_adam_object | 1 |
author_GND | (DE-588)171991923 |
building | Verbundindex |
bvnumber | BV012807913 |
classification_rvk | XD 7255 XD 7950 |
ctrlnum | (OCoLC)313614372 (DE-599)BVBBV012807913 |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02608nam a2200541 cb4500</leader><controlfield tag="001">BV012807913</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210702 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">991012s1999 gw d||| |||| 10||| ger d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805568967</subfield><subfield code="c">kart. : DM 240.00</subfield><subfield code="9">3-8055-6896-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)313614372</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012807913</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 7255</subfield><subfield code="0">(DE-625)152592:13134</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 7950</subfield><subfield code="0">(DE-625)152605:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Inactivated influenza vaccines prepared in cell culture</subfield><subfield code="b">proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables</subfield><subfield code="c">Organized and sponsored by the National Institute for Biological Standards and Control (NIBSC) ... Vol. ed. Fred Brown ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IX, 209 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in biological standardization</subfield><subfield code="v">98</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Virusimpfstoff</subfield><subfield code="0">(DE-588)4257636-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biologische Standardisierung</subfield><subfield code="0">(DE-588)4336303-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zellkultur</subfield><subfield code="0">(DE-588)4067547-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Influenzaviren</subfield><subfield code="0">(DE-588)4254831-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Grippe</subfield><subfield code="0">(DE-588)4022090-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1997</subfield><subfield code="z">Potters Bar</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Influenzaviren</subfield><subfield code="0">(DE-588)4254831-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Virusimpfstoff</subfield><subfield code="0">(DE-588)4257636-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Zellkultur</subfield><subfield code="0">(DE-588)4067547-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Biologische Standardisierung</subfield><subfield code="0">(DE-588)4336303-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Grippe</subfield><subfield code="0">(DE-588)4022090-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Virusimpfstoff</subfield><subfield code="0">(DE-588)4257636-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Zellkultur</subfield><subfield code="0">(DE-588)4067547-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Biologische Standardisierung</subfield><subfield code="0">(DE-588)4336303-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brown, Fred</subfield><subfield code="d">1925-2004</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)171991923</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Institute for Biological Standards and Control (Großbritannien)</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5123324-1</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in biological standardization</subfield><subfield code="v">98</subfield><subfield code="w">(DE-604)BV000000884</subfield><subfield code="9">98</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008711074&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008711074</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1997 Potters Bar gnd-content |
genre_facet | Konferenzschrift 1997 Potters Bar |
id | DE-604.BV012807913 |
illustrated | Illustrated |
indexdate | 2024-07-09T18:34:01Z |
institution | BVB |
institution_GND | (DE-588)5123324-1 |
isbn | 3805568967 |
language | German |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008711074 |
oclc_num | 313614372 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-12 DE-11 |
owner_facet | DE-355 DE-BY-UBR DE-12 DE-11 |
physical | IX, 209 S. graph. Darst. |
publishDate | 1999 |
publishDateSearch | 1999 |
publishDateSort | 1999 |
publisher | Karger |
record_format | marc |
series | Developments in biological standardization |
series2 | Developments in biological standardization |
spelling | Inactivated influenza vaccines prepared in cell culture proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables Organized and sponsored by the National Institute for Biological Standards and Control (NIBSC) ... Vol. ed. Fred Brown ... Basel [u.a.] Karger 1999 IX, 209 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Developments in biological standardization 98 Literaturangaben Virusimpfstoff (DE-588)4257636-2 gnd rswk-swf Biologische Standardisierung (DE-588)4336303-9 gnd rswk-swf Zellkultur (DE-588)4067547-6 gnd rswk-swf Influenzaviren (DE-588)4254831-7 gnd rswk-swf Grippe (DE-588)4022090-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1997 Potters Bar gnd-content Influenzaviren (DE-588)4254831-7 s Virusimpfstoff (DE-588)4257636-2 s Zellkultur (DE-588)4067547-6 s Biologische Standardisierung (DE-588)4336303-9 s DE-604 Grippe (DE-588)4022090-4 s Brown, Fred 1925-2004 Sonstige (DE-588)171991923 oth National Institute for Biological Standards and Control (Großbritannien) Sonstige (DE-588)5123324-1 oth Developments in biological standardization 98 (DE-604)BV000000884 98 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008711074&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Inactivated influenza vaccines prepared in cell culture proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables Developments in biological standardization Virusimpfstoff (DE-588)4257636-2 gnd Biologische Standardisierung (DE-588)4336303-9 gnd Zellkultur (DE-588)4067547-6 gnd Influenzaviren (DE-588)4254831-7 gnd Grippe (DE-588)4022090-4 gnd |
subject_GND | (DE-588)4257636-2 (DE-588)4336303-9 (DE-588)4067547-6 (DE-588)4254831-7 (DE-588)4022090-4 (DE-588)1071861417 |
title | Inactivated influenza vaccines prepared in cell culture proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables |
title_auth | Inactivated influenza vaccines prepared in cell culture proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables |
title_exact_search | Inactivated influenza vaccines prepared in cell culture proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables |
title_full | Inactivated influenza vaccines prepared in cell culture proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables Organized and sponsored by the National Institute for Biological Standards and Control (NIBSC) ... Vol. ed. Fred Brown ... |
title_fullStr | Inactivated influenza vaccines prepared in cell culture proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables Organized and sponsored by the National Institute for Biological Standards and Control (NIBSC) ... Vol. ed. Fred Brown ... |
title_full_unstemmed | Inactivated influenza vaccines prepared in cell culture proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables Organized and sponsored by the National Institute for Biological Standards and Control (NIBSC) ... Vol. ed. Fred Brown ... |
title_short | Inactivated influenza vaccines prepared in cell culture |
title_sort | inactivated influenza vaccines prepared in cell culture proceedings of a meeting national institute for biological standards and control potters bar herts u k september 26 27 1997 44 tables |
title_sub | proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables |
topic | Virusimpfstoff (DE-588)4257636-2 gnd Biologische Standardisierung (DE-588)4336303-9 gnd Zellkultur (DE-588)4067547-6 gnd Influenzaviren (DE-588)4254831-7 gnd Grippe (DE-588)4022090-4 gnd |
topic_facet | Virusimpfstoff Biologische Standardisierung Zellkultur Influenzaviren Grippe Konferenzschrift 1997 Potters Bar |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008711074&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV000000884 |
work_keys_str_mv | AT brownfred inactivatedinfluenzavaccinespreparedincellcultureproceedingsofameetingnationalinstituteforbiologicalstandardsandcontrolpottersbarhertsukseptember2627199744tables AT nationalinstituteforbiologicalstandardsandcontrolgroßbritannien inactivatedinfluenzavaccinespreparedincellcultureproceedingsofameetingnationalinstituteforbiologicalstandardsandcontrolpottersbarhertsukseptember2627199744tables |